ArticleEMBO molecular medicine2019

Targeting TGFβR2-mutant tumors exposes vulnerabilities to stromal TGFβ blockade in pancreatic cancer.

Huocong Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.